• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Public Health

Support sheets for patients did not reduce low value screening tests

byJames Jiang
December 30, 2015
in Public Health
Reading Time: 2 mins read
Mortality after trauma increasingly due to preexisting conditions
Share on FacebookShare on Twitter

 

1. In this randomized controlled trial, providing patients with single-page, evidence-based decision support sheets for low value or potentially low value-screening tests did not change their intention to receive these tests.

2. The investigators used four types of single-page decision support sheets, using words, numbers, numbers plus narratives, or numbers plus a framed presentation. None of the four types were significantly more effective than the others.

Evidence Rating Level: 1 (Excellent)      

Study Rundown: Inappropriate use of healthcare resources, especially in the form of low-value diagnostic testing, has been increasingly identified as a problem. In addition to the significant cost incurred by these services, many screening tests have been found to deliver net harm on a population-based level. Patient education is one potential site of intervention to decrease the prevalence of inappropriate testing. This study aimed to identify if a brief, evidence-based decision support sheet would alter patient intention to receive low-value testing.

The study investigators used four types of single-page evidence-based decision support sheets (based on United States Preventative Service Task Force data) for low value or potentially low value-screening tests, which did not change patient intention to receive these tests. None of the four types were significantly more effective than the others. Strengths of the study include the randomized design. However, convenience sampling was used, which may over or under-represent certain patient populations, which may limit the generalizability of this study. Moreover, no control arm was included in the study, and the intervention arms were only compared against each other and their own pre-intervention survey results.

RELATED REPORTS

Deep-learning model achieved high diagnostic performance for diabetic macular edema detection using optical coherence tomography (OCT) scans

FDA-cleared AI devices rarely have patient outcome data

Apixaban (Eliquis) is associated with reduced rates of ischemic stroke and bleeding in patients with atrial fibrillation and advanced chronic kidney disease compared with warfarin (Coumadin)

Click to read the study in JAMA Internal Medicine

Relevant Reading: The Harms of Screening

In-Depth [randomized controlled trial]: This randomized trial collected data a total of 775 patients across 32 clinicians associated with the Duke Primary Care Research Consortium. Patients aged 50-85 years received information about 1 of 3 screening services that were of net harm (prostate cancer screening in men 50-69), or low benefit (osteoporosis screening in women 50-64, or colorectal screening age 76-85). Patients were randomized to 1 of 4 intervention arms: single-page decision support sheets using words, umbers, numbers plus narratives, or numbers plus a framed presentation. The primary outcome was measured by survey, asking intention to accept screening on a scale of 1 (strongly disagree) to 5 (strongly agree).

At baseline, all intervention arms had high intention to accept screening (ranging from 3.53 to 3.71 out of 5). The intervention arms did not significantly differ in change in intention (p=0.57). Only the narrative format group had lower intention to accept screening after intervention (-0.12, 95% CI -0.22 – -0.02). There was improvement in a few secondary outcomes (disease specific knowledge, perceived disease severity, disease-specific screening attitudes, and self-efficacy for screening).

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Previous Post

Repeat opioid overdose linked to continued use of high-dose prescriptions

Next Post

Treatment risk may outweigh benefit for asymptomatic chorioamnionitis-exposed infants

RelatedReports

Endocrinology

Deep-learning model achieved high diagnostic performance for diabetic macular edema detection using optical coherence tomography (OCT) scans

September 10, 2026
Public Health

FDA-cleared AI devices rarely have patient outcome data

September 10, 2026
Nephrology

Apixaban (Eliquis) is associated with reduced rates of ischemic stroke and bleeding in patients with atrial fibrillation and advanced chronic kidney disease compared with warfarin (Coumadin)

September 9, 2026
Artificial Intelligence

Artificial intelligence based clinical exam training significantly improved medical students’ standardized clinical exam performance

September 9, 2026
Next Post
Stochastic resonance stimulation may decrease apnea of prematurity

Treatment risk may outweigh benefit for asymptomatic chorioamnionitis-exposed infants

Adverse pregnancy outcomes associated with thrombophilias [Classics Series]

The EMGT: Reducing intraocular pressure slows progression of glaucoma [Classics Series]

Medicaid home-visitation program linked to reduced infant mortality

Planned out-of-hospital birth associated with higher mortality

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Deep-learning model achieved high diagnostic performance for diabetic macular edema detection using optical coherence tomography (OCT) scans
  • FDA-cleared AI devices rarely have patient outcome data
  • Apixaban (Eliquis) is associated with reduced rates of ischemic stroke and bleeding in patients with atrial fibrillation and advanced chronic kidney disease compared with warfarin (Coumadin)
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.